Search Results 671-680 of 21791 for alzheimers

  1. Neurology - Clinical trials - Mayo Clinic

    There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).

  2. A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease ... Alzheimer's disease (AD) ...

  3. Funding - Translational Neuropathology Laboratory - Mayo Clinic Research

    ... Alzheimer's Association. Grants. INVESTIGATOR & ROLE. GRANT TITLE. FUNDING SOURCE. DURATION. Melissa E. Murray, Ph.D., co-investigator; Nilufer Ertekin-Taner ...

  4. Neurology - Clinical trials

    ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

  5. TUESDAY Q & A: Regular physical exercise has powerful effect on brain health

    ... Alzheimer's and improving brain function — even in those with Alzheimer's. One Mayo Clinic study showed that those who regularly engaged in moderate ...

  6. Jonathan Graff-Radford, M.D. - Doctors and Medical Staff - Mayo Clinic

    Alzheimer's Disease Treatment Clinic · Behavioral Neurology. Location. Rochester, Minnesota. Languages. English. Existing patients. Send a secure message via ...

  7. Neurology - Clinical trials

    ... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.

  8. Contact - Mayo Clinic Research

    Contact the Aging and Dementia Imaging Research Lab at Mayo Clinic with inquiries about imaging research in cognitive aging and Alzheimer's disease. ADIR ...

  9. An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia - Mayo Clinic

    ... Alzheimer Cognitive Composite (PACC), in amyloid-positive participants who are asymptomatic at risk for developing Alzheimer's dementia. Participation ...

  10. A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease - Mayo Clinic

    Clinical Trials · A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease · More about research at Mayo Clinic · Mayo ...